EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Second-tier genetics improves newborn screening accuracy for SCID and other T cell deficiencies

Annelotte J Duintjer iD, Maartje Blom iD, Robbert G M Bredius iD, Ingrid Pico-Knijnenburg iD, Adinda Heuperman iD, Hennie Hodemaekers iD, Sandra Imholz iD, Martijn E T Dollé iD, Ruben B Brandsema iD, Lisette van de Corput iD, Stefanie S Henriet iD, Taco W Kuijpers iD und 7 weitere

Journal of Human Immunity · 07.09.2026 · 2 (5)

DOI: 10.70962/jhi.20260031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Human Immunity, online erschienen am 16.07.2026. Verfasst von Annelotte J Duintjer und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Laboratory for Pediatric Immunology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Nether…. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Takeda Pharmaceuticals International AG, Illumina, Inc., Dutch Ministry of Health, Welfare and Sport.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Newborn screening (NBS) based on quantifying T cell receptor excision circles (TRECs) is highly sensitive for detecting severe combined immunodeficiency (SCID), but frequently results in false-positive referrals. These referrals contribute to parental distress, increased clinical workload, additional interventions, and costs. To increase the positive predictive value (PPV) for SCID and other T cell deficiencies with a genetic cause, we evaluated next-generation sequencing (NGS) as second-tier testing after TREC analysis. Targeted sequencing was performed on dried blood spots of 68 newborns referred from TREC-based NBS, and results were integrated with collected long-term follow-up data. A safety net algorithm was applied to maintain high sensitivity for SCID by directly referring newborns with profoundly reduced TRECs, increasing the PPV from 22% to 55% without missing patients with severe immunological phenotypes. Therefore, the clinical impact of not identifying non-severe T cell lymphopenia patients without a genetic diagnosis appears limited. These results demonstrate that second-tier NGS in TREC-based NBS improves screening accuracy for SCID and other T cell deficiencies.

Autor:innen und Institutionen

  • Department of Pediatrics, Laboratory for Pediatric Immunology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands.
  • Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands.
  • Centre for Health Protection, Dutch National Institute for Public Health and the Environment, Bilthoven, Netherlands.
  • Department of Pediatrics, Infectious Diseases and Immunology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
  • Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht, Netherlands.
  • Department of Pediatric Immunology and Infectious Diseases, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, Netherlands.

ORCID-Profile: Annelotte J Duintjer, Maartje Blom, Robbert G M Bredius, Ingrid Pico-Knijnenburg, Adinda Heuperman, Hennie Hodemaekers, Sandra Imholz, Martijn E T Dollé, Ruben B Brandsema, Lisette van de Corput, Stefanie S Henriet, Taco W Kuijpers, Joris M van Montfrans, Clementien L Vermont, Gijs T J van Well, Evelien Zonneveld-Huijssoon, Els Voorhoeve, Mariëlle E van Gijn, Mirjam van der Burg

Förderung

  • Takeda Pharmaceuticals International AG
  • Illumina, Inc.
  • Dutch Ministry of Health, Welfare and Sport
  • National Institute for Public Health and the Environment
  • Jeffrey Modell Foundation
  • Zeldzame Ziekten Fonds

Zitieren

APA

Duintjer, A. J., Blom, M., Bredius, R. G. M., Pico-Knijnenburg, I., Heuperman, A., Hodemaekers, H., Imholz, S., Dollé, M. E. T., Brandsema, R. B., van de Corput, L., Henriet, S. S., Kuijpers, T. W., van Montfrans, J. M., Vermont, C. L., van Well, G. T. J., Zonneveld-Huijssoon, E., Voorhoeve, E., van Gijn, M. E., & van der Burg, M. (2026). Second-tier genetics improves newborn screening accuracy for SCID and other T cell deficiencies. Journal of Human Immunity, 2(5). https://doi.org/10.70962/jhi.20260031

Vancouver

Duintjer AJ, Blom M, Bredius RGM, Pico-Knijnenburg I, Heuperman A, Hodemaekers H, et al. Second-tier genetics improves newborn screening accuracy for SCID and other T cell deficiencies. Journal of Human Immunity. 2026;2(5). doi:10.70962/jhi.20260031

BibTeX
@article{Duintjer2026,
  author = {Duintjer, Annelotte J and Blom, Maartje and Bredius, Robbert G M and Pico-Knijnenburg, Ingrid and Heuperman, Adinda and Hodemaekers, Hennie and Imholz, Sandra and Dollé, Martijn E T and Brandsema, Ruben B and van de Corput, Lisette and Henriet, Stefanie S and Kuijpers, Taco W and van Montfrans, Joris M and Vermont, Clementien L and van Well, Gijs T J and Zonneveld-Huijssoon, Evelien and Voorhoeve, Els and van Gijn, Mariëlle E and van der Burg, Mirjam},
  title = {Second-tier genetics improves newborn screening accuracy for SCID and other T cell deficiencies},
  journal = {Journal of Human Immunity},
  year = {2026},
  volume = {2},
  number = {5},
  doi = {10.70962/jhi.20260031}
}
Kostenlos starten →